The aryl hydrocarbon receptor (AhR) is a signal transduction protein that binds chlorinated dioxins and other xenobiotics and mediates their effects on gene expression in various organs including the prostate. We have utilized transgenic adenocarcinoma mouse prostate (TRAMP) mice to test the hypothesis that alterations in AhR signaling pathway can affect prostate cancer development. TRAMP mice on a C57BI/6J backgroundi rarely develop macroscopic prostate cancer in our lab (1 of 27 mice), but their heterozygous (Ahr ) and homozygous (Ahr-/-) AhR mutant TRAMP siblings rapidly develop large tumors (27 of 65 and 10 of 15 mice, respectively). These preliminary results demonstrate that the AhR can greatly affect prostate cancer progression, and suggest that Ahr may be involved in prostate tumor suppression. One objective of the proposed research is to elucidate the mechanisms by which AhR regulates prostate tumor progression. The effects of Ahr genotype on microscopic and macroscopic prostate cancer development will be systematically characterized in TRAMP mice at 5-week intervals starting at 5 weeks of age. Large T antigen and AhR levels will be investigated as they relate to prostate pathology. Loss of heterozygosity of the AhR gene will also be analyzed. We will also test the hypothesis that activation of the AhR signaling pathway by a selective AhR: modulator (6-methyl-1, 3,8-trichlorodibenzofuran; 6-MCDF) can inhibit prostate cancer. The proposed studies will help elucidate the biochemical basis for effects of the AhR signaling pathway on prostate cancer, and begin in vivo testing of selective AhR agonists as potential new therapeutics for treating this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32ES012352-01
Application #
6650065
Study Section
Special Emphasis Panel (ZRG1-F09 (20))
Program Officer
Shreffler, Carol K
Project Start
2003-04-01
Project End
2005-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
1
Fiscal Year
2003
Total Cost
$41,608
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Pharmacy
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Fritz, Wayne A; Lin, Tien-Min; Safe, Stephen et al. (2009) The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice. Biochem Pharmacol 77:1151-60
Fritz, Wayne A; Lin, Tien-Min; Peterson, Richard E (2008) The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. Carcinogenesis 29:1077-82
Fritz, Wayne A; Lin, Tien-Min; Cardiff, Robert D et al. (2007) The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis 28:497-505
Fritz, Wayne A; Lin, Tien-Min; Moore, Robert W et al. (2005) In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on the prostate and its response to castration in senescent C57BL/6J mice. Toxicol Sci 86:387-95